TrialPediatric blood & cancer2016

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Determine the Effect of Romiplostim on Health-Related Quality of Life in Children with Primary Immune Thrombocytopenia and Associated Burden in Their Parents.

Susan D Mathias et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.